Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AMDL seeks partner for Combination Immunogene Therapy

May 5, 2004

Panacea collaborates with M.D. Anderson Cancer Center on HAAH program

May 5, 2004

MAGNET liver cancer trial stopped early

May 5, 2004

Interim results from phase II trial of Metastat

May 5, 2004

Celgene to stop Revlimid phase III trials in melanoma

May 4, 2004

New antiangiogenic agents in early development at Boehringer Ingelheim

May 4, 2004

Lilly claims TGF-beta receptor kinase inhibitors for cancer and other disorders

May 4, 2004

Antineoplastic effects of pioglitazone on malignant tumor growth in rat glioma model

May 4, 2004

Interim results for Theralux in NHL

May 3, 2004

S-3304 reported to inhibit MMP activity in advanced cancer

May 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...